Naloxone 0,4 Mg/ml Ampoule
Orpha Swiss GmbH Switzerland flag Switzerland
Abstract ID:
Opioid receptor antagonist reducing opioid induced respiratory depression
Send an Inquiry
RE:
Participants
You

Strong Opioid-antagonist for postoperative use and in emergency after overdose of e.g. Heroine. Target groups are anaesthetists and hospitals (accident and emergency units). The product is a generic and supplied in packs of 10 ampoules.

GO PREMIUM TO GET PATENT INFORMATION
Type of Business Relationship Sought

Country specific or regional distribution contract.

FEATURED
Last Updated Oct 2014
Technology Type THERAPEUTIC
Phase of Development REGISTERED / FINISHED PRODUCT
CORPORATION
Company Logo

Opportunity Contact